Episode 186: Rebecca Robbins on Moderna v. NIH, plus psilocybin as a medicine

Rebecca Robbins of the New York Times joins us to discuss the escalating tension between Moderna and the National Institutes of Health over just who invented a Covid-19 vaccine. Then, STAT's Olivia Goldhill calls in to explain Compass Pathways' promising results using psilocybin as a treatment for depression and the future of the nascent field of psychedelic medicines. We also discuss the latest news in the life sciences, including pills for Covid-19, the next FDA commissioner, and whether Pfizer CEO Albert Bourla listens to Joe Rogan.

Episode metadata supplied by the publisher feed · Published Nov 11, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 186: Rebecca Robbins on Moderna v. NIH, plus psilocybin as a medicine

0:00 30:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 30 minutes long.

When was this The Readout Loud episode published?

This episode was published on November 11, 2021.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!